Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

E 643

Known as: E-643, E643 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryTo determine whether E-643, a new α-blocking agent, would reduce the blood pressure, regardless of the posture, a 1 mg… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1985
1985
Present study was undertaken to elucidate the effects of E-643, on blood pressure, urinary electrolyte (U-Na, U-K) and… Expand
Is this relevant?
1982
1982
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with… Expand
Is this relevant?
1981
1981
  • T. Shoji
  • Japanese journal of pharmacology
  • 1981
  • Corpus ID: 18935434
Effectiveness of E-643, a newly developed alpha-blocker, and four alpha-antagonists in blocking pre- and postsynaptic alpha… Expand
Is this relevant?
1981
1981
Using the isolated and blood-perfused dog atrial preparation, chronotropic and inotropic responses to 3 kinds of alpha-adrenergic… Expand
  • figure 1
Is this relevant?
1980
1980
Postsynaptic alpha-receptor blocking properties of E-643 were studied in vivo and in vitro and compared with these same… Expand
Is this relevant?
1980
1980
The effect of 2-[N-(n-butyloyl)homopiperazin-N'-yl]-4-amino-6,7-dimethoxy quinazoline hydrochloride (E-643), a new alpha… Expand
Is this relevant?
1980
1980
To further clarify the hypotensive mechanism of adrenergic alpha blockers, effects of several alpha blockers on systemic blood… Expand
Is this relevant?
1977
1977
Using a continuous systolic monitor, effects of oral administration of three alpha-adrenergic blockers, i.e. phenoxybenzamine… Expand
Is this relevant?